GH Research
part a single dose and part safety preferred term | GH Research
Company
Deck Type
Deck date
March 2023
Slide
11 of 30
Similar slides by GH Research
See diffirences between slides (animation)
Investor Presentation
November 2023
single dose and safety and further results | GH Research
Investor Presentation
November 2023
phase single dose and phase safety | GH Research
Investor Presentation
November 2023
part a single dose and part safety preferred term | GH Research
Investor Presentation
May 2023
single dose and safety and further results | GH Research
Related slides by other companies
Exscientia
Investor Presentation
November 2023
elucidate phase ongoing in advanced solid | Exscientia
DICE Therapeutics
Investor Presentation
March 2023
single dose ranging phase potentially unlocks other sizeable indications | DICE Therapeutics
Exscientia
Investor Day
January 2024
elucidate phase ongoing in advanced solid | Exscientia
Apexigen
Investor Presentation
September 2022
single dose of turns cold tumor hot data presented at some | Apexigen
Other recent decks by GH Research
See all presentations (4 decks)
Investor Presentation
November 2023
Investor Presentation
May 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights